How the Pricing Strategy of 2nd Generation HCV Direct Antiviral Agents Can Affect the Number of Treated Patients in Italy and the National Drug Budget
Abstract
Authors
E.P. Lanati D. Lidonnici C. Cammà
E.P. Lanati D. Lidonnici C. Cammà
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now